Showing 4 posts of 4 posts found.


LSD treatment for Alzheimer’s patients proves safe in recent trial

December 19, 2019
Business Services Alzheimer's, FDA, LSD, Magic mushrooms, psilocybin

The results of a Phase 1 clinical trial shows that Lysergic Acid Diethylamide (LSD) can be microdosed safely, and potentially …


FDA fast-tracks psilocybin treatment for major depressive disorder

November 25, 2019
Sales and Marketing Controlled Substance Act, FDA, breakthrough therapy, major depressive disorder, psilocybin

The FDA has granted a Breakthrough Therapy designation to the Usona Institute for its trial use of psilocybin in the …

Johns Hopkins researchers to study psilocybin as a treatment for anorexia in Phase 1 trial

August 28, 2019
Research and Development Johns Hopkins, Magic mushrooms, anorexia, mushrooms, pharma, psilocybin

Scientists at Johns Hopkins University are exploring psilocybin as a potential treatment for chronic anorexia nervosa. Researchers at Johns Hopkins …


Illegal psilocybin shows promise in treatment of depression

December 1, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Johns Hopkins, Magic mushrooms, psilocybin

A double-blind study of psilocybin, the hallucinogenic drug chemical found in ‘magic mushrooms’,  has been found to have substantial mental …

Latest content